IgG class antibodies against human IgM were detected in a human subject up to a titer of 1:1024 against 5 of a group of 23 monoclonal Waldenstr-m macroglobulins. Inhibition studies confirmed at least one antigenic determinant shared by the 5 IgMs. The determinant was present on the ji chain but required tertiary structure for its full expression. Inhibition of the reaction between the antibodies to IgM and erythrocytes coated with 2 of the 5 IgMs was obtained at titers of 1:2 to 1:16 with 51.0% of 300 normal sera (85.2% of sera from 122 Caucasian, 26.1% of sera from 23 Negro, and 27.7% of sera from 155 Japanese individuals). This inhibition was independent of the serum IgM concentration. Family studies indicated that the determinant was inherited according to basic Mendelian laws and appears to be the first allotypic marker on human serum IgM. We have designated it Mm 1.
Numerous studies have been reported on the inherited allotypic markers on the y-heavy chains of IgG molecules (Gm markers) and on K-type light chains (Inv markers) (1, 2) . An allotypic marker on the a-heavy chains of IgA molecules was studied with a human serum containing antibodies against one of a group of IgA myeloma proteins and erythrocytes coated with the specific IgA myeloma protein by the chromic chloride method (3) . This marker was originally designated Am, and is probably identical to the marker Am2 on IgA2 molecules (4) . It has been redesignated A2m1 with the discovery of its allele designated A2m2, by Van Loghem et al.
(submitted for publication).
Attempts by several laboratories over the past 10 years to detect IgM allotypic determinants by similar techniques have been less fruitful (5) . Anti-IgM antibodies were detected in an earlier study in only 16 of 378 sera (4.2%), including subjects who had had multiple blood transfusions or several pregnancies (5) . These antibodies were of low titer, directed in each case against only one of a group of 15 Waldenstrom macroglobulins, and slightly inhibited in two cases by some normal sera (6) . We report here studies on a subject whose serum contained IgG-class antibodies in high titer against five of a group of 23 monoclonal IgM macroglobulins. Inhibition experiments indicated a specificity against one or more determinants shared by the five IgM proteins, and the evidence indicates that this shared determinant represents an inherited characteristic ("allotype").
MATERIALS AND METHODS
The chromic chloride method (6) was used to coat erythrocytes from a group 0, Rh-positive subject with purified proteins from a group including 23 Table 2 . Inhibition was obtained in many of the sera from Japanese individuals at a dilution of only 1: 2; the majority of inhibitory sera were effective at a dilution of 1:4 or 1:8. The differences in the percentages of inhibitory sera from Caucasians compared with those from Negroes and Japanese were statistically significant. The percentages of inhibitors in sera from Negro and Japanese individuals were not significantly different. The majority of sera were comparable in their inhibitory titers against both proteins or their inability to inhibit both proteins. However, 18 of 300 sera (6.0%) demonstrated discordance in that they inhibited one protein but not the other. Sixteen subjects inhibited only IgM 7 and two inhibited only IgM 11; the inhibitory titers ranged from 1:2 to 1:8. Six of 306 sera (2.0%) were excluded from inhibitory studies as they contained anti-IgM antibodies. Table 3 summarizes data on the presence of the postulated IgM determinant among 69 children in 37 Japanese families. In 17 families where both parents were negative for the determinant, none of the 29 children was positive. Serum IgM concentrations were measured in 25 members (14 positive, 11 negative) in six Japanese families; there was no statistically significant correlation between the serum IgM concentration and the presence of the determinant. The serum concentration of IgM ranged from 32-140 mg/100 ml (mean 65 mg/100 ml) in positive sera and from 53-130 mg/100 ml (mean 84 mg/100 ml) in negative sera.
DISCUSSION
The pathogenesis of these anti-IgM antibodies is unknown. Subject R.K. has no history of infusion of parenteral blood, plasma, or blood proteins and no history of earlier pregnancy that might account for initial sensitization. The patterns of inhibition and specificity of the anti-IgM antibodies in her infant suggest that the infant received the anti-IgM antibodies by transfer of maternal IgG across the placenta.
The ability of each of the five IgMs to inhibit the reaction of serum R.K. antibodies with each of the same five IgM coats strongly suggests at least one determinant common to these proteins. The determinant is not dependent on the L-chain type, and the failure of polymer IgA myeloma proteins to inhibit the reaction excluded J-chain. It appears that u and L chains are required in their normal association as the 7S subunits of IgM to express the determinant although we feel that it is located in the Fc region of the M chain. The dependence of antigenicity on the association of H and L chains with intact disulfide bonds has been described for y chain allotypic markers Gm(b2), Gm(f), and Gm(z) on IgG molecules (1, 2) and for an individual antigenic specificity on the Lu chain of a monoclonal IgM M6 (11) . We have thus far been unable to verify the location of the determinant in the FcMu region since the isolation procedures for the fragments apparently destroy its antigenicity in our test system.
There are several points that indicate that this system is more complex than that of a single determinant. The titers against proteins 7, 11 , and 21 were consistently higher, and these higher titers apparently accounted for the transfer of only these specificities into the serum of the infant. The titer differences might reflect various degrees of response to a common antigenic determinant with minor steric or conformational changes between proteins 7, 11, and 21 and proteins 8 and 10. Alternatively, they might reflect additional antibody specificities against additional determinants restricted Further studies with R.K. anti-IgM antibodies have been restricted by the small volume of available R.K. serum. Rabbit and goat antisera to IgMs 7, 8, 10 , and 11 were therefore prepared and absorbed with Mm 1-negative IgMs to remove anti-IgM-class and L-chain specificities. Thus far, antibodies have not been found in heterologous species or in other humans with the specificities of the anti-IgM antibodies in serum R.K.
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